Ionis Pharmaceuticals (IONS) Net Cash Flow Growth (1y) (2010 - 2026)
Ionis Pharmaceuticals (IONS) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
198.34% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
467.41% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-14,223.53% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
453.08% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ionis Pharmaceuticals |
12.23 Bn |
10.31 Bn |
243.11 Mn |
-1,008.20% |
| Date | Value |
|---|
| Mar 31, 2026 |
-1,008.20% |
| Dec 31, 2025 |
136.90% |
| Sep 30, 2025 |
2.13% |
| Jun 30, 2025 |
159.26% |
| Mar 31, 2025 |
143.54% |
| Dec 31, 2024 |
-296.35% |
| Sep 30, 2024 |
155.47% |
| Jun 30, 2024 |
-147.43% |
| Mar 31, 2024 |
-254.87% |
| Dec 31, 2023 |
219.99% |
| Sep 30, 2023 |
64.86% |
| Jun 30, 2023 |
673.14% |
| Mar 31, 2023 |
109.94% |
| Dec 31, 2022 |
-116.53% |
| Sep 30, 2022 |
-404.36% |
| Jun 30, 2022 |
-113.38% |
| Mar 31, 2022 |
-2,065.00% |
| Dec 31, 2021 |
200.28% |
| Sep 30, 2021 |
-33.87% |
| Jun 30, 2021 |
243.55% |
